293 related articles for article (PubMed ID: 28472632)
1. The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization.
Mouri A; Noda Y; Niwa M; Matsumoto Y; Mamiya T; Nitta A; Yamada K; Furukawa S; Iwamura T; Nabeshima T
Behav Brain Res; 2017 Jun; 329():157-165. PubMed ID: 28472632
[TBL] [Abstract][Full Text] [Related]
2. Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat.
Koprich JB; Campbell NG; Lipton JW
Brain Res Dev Brain Res; 2003 Dec; 147(1-2):177-82. PubMed ID: 14741762
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus.
Martínez-Turrillas R; Moyano S; Del Río J; Frechilla D
Neurosci Lett; 2006 Jul; 402(1-2):126-30. PubMed ID: 16644117
[TBL] [Abstract][Full Text] [Related]
4. Region-specific expression of brain-derived neurotrophic factor splice variants in morphine conditioned place preference in mice.
Meng M; Zhao X; Dang Y; Ma J; Li L; Gu S
Brain Res; 2013 Jun; 1519():53-62. PubMed ID: 23623815
[TBL] [Abstract][Full Text] [Related]
5. Administration of MDMA to ethanol-deprived rats increases ethanol operant self-administration and dopamine release during reinstatement.
Moreno-Sanz G; O'Shea E; Orio L; Escobedo I; González-Cuevas G; Navarro M; Colado MI; López-Moreno JA
Int J Neuropsychopharmacol; 2009 Aug; 12(7):929-40. PubMed ID: 19236733
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.
Górska AM; Kamińska K; Wawrzczak-Bargieła A; Costa G; Morelli M; Przewłocki R; Kreiner G; Gołembiowska K
Neurotox Res; 2018 Apr; 33(3):532-548. PubMed ID: 29134560
[TBL] [Abstract][Full Text] [Related]
7. 3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice.
Trigo JM; Renoir T; Lanfumey L; Hamon M; Lesch KP; Robledo P; Maldonado R
Biol Psychiatry; 2007 Sep; 62(6):669-79. PubMed ID: 17306775
[TBL] [Abstract][Full Text] [Related]
8. Reinforcing effects of certain serotonin-releasing amphetamine derivatives.
Marona-Lewicka D; Rhee GS; Sprague JE; Nichols DE
Pharmacol Biochem Behav; 1996 Jan; 53(1):99-105. PubMed ID: 8848466
[TBL] [Abstract][Full Text] [Related]
9. Role of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent mice.
Vidal-Infer A; Roger-Sánchez C; Daza-Losada M; Aguilar MA; Miñarro J; Rodríguez-Arias M
PLoS One; 2012; 7(8):e43107. PubMed ID: 22916213
[TBL] [Abstract][Full Text] [Related]
10. Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors.
Rodríguez-Arias M; Valverde O; Daza-Losada M; Blanco-Gandía MC; Aguilar MA; Miñarro J
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():77-84. PubMed ID: 23959085
[TBL] [Abstract][Full Text] [Related]
11. Adaptive Plasticity in the Hippocampus of Young Mice Intermittently Exposed to MDMA Could Be the Origin of Memory Deficits.
Abad S; Camarasa J; Pubill D; Camins A; Escubedo E
Mol Neurobiol; 2016 Dec; 53(10):7271-7283. PubMed ID: 26687233
[TBL] [Abstract][Full Text] [Related]
12. CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.
Touriño C; Ledent C; Maldonado R; Valverde O
Biol Psychiatry; 2008 Jun; 63(11):1030-8. PubMed ID: 17950256
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain.
Zhang L; Shirayama Y; Shimizu E; Iyo M; Hashimoto K
Eur J Pharmacol; 2006 Aug; 544(1-3):1-9. PubMed ID: 16859675
[TBL] [Abstract][Full Text] [Related]
14. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice.
Deltheil T; Guiard BP; Cerdan J; David DJ; Tanaka KF; Repérant C; Guilloux JP; Coudoré F; Hen R; Gardier AM
Neuropharmacology; 2008 Nov; 55(6):1006-14. PubMed ID: 18761360
[TBL] [Abstract][Full Text] [Related]
15. Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.
Gudelsky GA; Yamamoto BK
Pharmacol Biochem Behav; 2008 Aug; 90(2):198-207. PubMed ID: 18035407
[TBL] [Abstract][Full Text] [Related]
16. Long-term compulsive exercise reduces the rewarding efficacy of 3,4-methylenedioxymethamphetamine.
Chen HI; Kuo YM; Liao CH; Jen CJ; Huang AM; Cherng CG; Su SW; Yu L
Behav Brain Res; 2008 Feb; 187(1):185-9. PubMed ID: 17949827
[TBL] [Abstract][Full Text] [Related]
17. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of intravenous R,S-(+/-)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its S(+)- and R(-)-enantiomers on dopamine transmission and extracellular signal regulated kinase phosphorylation (pERK) in the rat nucleus accumbens shell and core.
Acquas E; Pisanu A; Spiga S; Plumitallo A; Zernig G; Di Chiara G
J Neurochem; 2007 Jul; 102(1):121-32. PubMed ID: 17564678
[TBL] [Abstract][Full Text] [Related]
19. The effects of methylenedioxymethamphetamine (MDMA, "Ecstasy") on monoaminergic neurotransmission in the central nervous system.
White SR; Obradovic T; Imel KM; Wheaton MJ
Prog Neurobiol; 1996 Aug; 49(5):455-79. PubMed ID: 8895996
[TBL] [Abstract][Full Text] [Related]
20. Involvement of 5-HT2A receptors in MDMA reinforcement and cue-induced reinstatement of MDMA-seeking behaviour.
Orejarena MJ; Lanfumey L; Maldonado R; Robledo P
Int J Neuropsychopharmacol; 2011 Aug; 14(7):927-40. PubMed ID: 20942998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]